128.39
-6.03
(-4.49%)
At close: January 10 at 3:30:00 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
84,149.00
116,929.00
135,392.00
118,443.00
134,783.00
Cost of Revenue
7,179.00
7,179.00
3,678.00
1,610.00
328.00
Gross Profit
76,970.00
109,750.00
131,714.00
116,833.00
134,455.00
Operating Expense
1,727,668.00
1,452,716.00
1,450,905.00
1,377,615.00
966,047.00
Operating Income
-1,650,698.00
-1,342,966.00
-1,319,191.00
-1,260,782.00
-831,592.00
Net Non Operating Interest Income Expense
161,811.00
161,267.00
60,045.00
4,560.00
60,383.00
Pretax Income
-1,469,915.00
-1,060,787.00
-1,182,678.00
-1,219,951.00
-774,740.00
Tax Provision
-10,024.00
-10,024.00
--
--
-53,228.00
Net Income Common Stockholders
-1,459,891.00
-1,050,763.00
-1,182,678.00
-1,219,951.00
-721,512.00
Diluted NI Available to Com Stockholders
-1,459,891.00
-1,050,763.00
-1,182,678.00
-1,219,951.00
-721,512.00
Basic EPS
-6.69
-4.82
-6.63
-9.05
-5.22
Diluted EPS
-6.69
-4.82
-6.63
-9.05
-5.22
Basic Average Shares
218,390.70
218,073.72
218,073.72
134,769.68
138,128.81
Diluted Average Shares
218,390.70
218,073.72
218,073.72
134,769.68
138,128.81
Rent Expense Supplemental
--
360.00
--
--
85.00
Total Expenses
1,734,847.00
1,459,895.00
1,454,583.00
1,379,225.00
966,375.00
Net Income from Continuing & Discontinued Operation
-1,459,891.00
-1,050,763.00
-1,182,678.00
-1,219,951.00
-721,512.00
Normalized Income
-1,460,003.23
-1,124,736.31
-1,244,382.00
-1,256,248.00
-721,512.00
Interest Income
--
164,252.00
64,164.00
11,263.00
69,791.00
Interest Expense
1,040.00
1,584.00
2,892.00
5,323.00
8,154.00
Net Interest Income
161,811.00
161,267.00
60,045.00
4,560.00
60,383.00
EBIT
-1,468,875.00
-1,059,203.00
-1,179,786.00
-1,214,628.00
-766,586.00
EBITDA
-1,408,347.00
-994,181.00
-1,114,355.00
-1,170,697.00
-723,124.00
Reconciled Cost of Revenue
7,179.00
7,179.00
3,678.00
1,610.00
328.00
Reconciled Depreciation
53,818.00
58,160.00
58,267.00
35,637.00
35,244.00
Net Income from Continuing Operation Net Minority Interest
-1,459,891.00
-1,050,763.00
-1,182,678.00
-1,219,951.00
-721,512.00
Total Unusual Items Excluding Goodwill
113.00
74,679.00
61,704.00
36,297.00
--
Total Unusual Items
113.00
74,679.00
61,704.00
36,297.00
--
Normalized EBITDA
-1,408,460.00
-1,068,860.00
-1,176,059.00
-1,206,994.00
-723,124.00
Tax Rate for Calcs
0.00
0.00
--
--
0.00
Tax Effect of Unusual Items
0.77
705.69
--
--
--
3/31/2021 - 10/24/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SUVENPHAR.NS Suven Pharmaceuticals Limited
1,061.95
-3.81%
HESTERBIO.NS Hester Biosciences Limited
2,264.20
-3.48%
THEMISMED.NS Themis Medicare Limited
260.65
-3.91%
ORCHPHARMA.NS Orchid Pharma Limited
1,844.90
-2.15%
SPARC.NS Sun Pharma Advanced Research Company Limited
183.52
-3.13%
TORNTPHARM.NS Torrent Pharmaceuticals Limited
3,274.45
-1.42%
NOVARTIND.BO Novartis India Limited
879.60
-3.76%
LASA.BO Lasa Supergenerics Limited
27.19
-3.89%
AARTIPHARM.NS Aarti Pharmalabs Limited
669.50
+1.42%
MEDICO.NS Medico Remedies Limited
63.14
+3.56%